Cargando…

ECOA-10. Integrated genomic and clinical analysis of BRAF-mutated glioma in adults

BRAF alterations are recognized as a significant driver of disease in pediatric low-grade glioma (pLGG) but the implications of BRAF alterations on the natural history and response to treatment are unclear in adult glioma. We characterized the molecular and clinical features of a multi-institutional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Langat, Pinky, Li, Taibo, Bi, Wenya Linda, Schreck, Karisa C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255413/ http://dx.doi.org/10.1093/noajnl/vdab070.010

Ejemplares similares

Integrated molecular and clinical analysis of BRAF-mutant glioma in adults
por: Schreck, Karisa C., et al.
Publicado: (2023)

ECOA-5. Integrative 3D spatial characterization of genomic and epigenomic intratumoral heterogeneity in glioblastoma
por: Mathur, Radhika, et al.
Publicado: (2021)

ECOA-6. Genomic and transcriptomic analyses reveal diverse mechanisms responsible for deregulation of epigenetic enzyme/modifier expression in glioblastoma
por: Maleszewska, Marta, et al.
Publicado: (2021)

ECOA-8. Lung adenocarcinoma brain metastasis prediction using tumor DNA methylation profiling
por: Zuccato, Jeffrey, et al.
Publicado: (2021)

ECOA-9. Integration of molecular and methylation classifications yields three meningioma groups and suggests chromosome 1p loss may be critical to the aggressive group
por: Bayley, James, et al.
Publicado: (2021)

BIMG-23. SINGLE-VOXEL VERSUS MULTI-SLICE MRSI IN PATIENTS WITH GLIOMA ON A KETOGENIC DIET INTERVENTION
por: Munjapara, Vasu, et al.
Publicado: (2021)

DDRE-31. FEASIBILITY AND BIOLOGIC ACTIVITY OF A KETOGENIC / INTERMITTENT FASTING DIET IN GLIOMA PATIENTS
por: Schreck, Karisa, et al.
Publicado: (2021)

ECOA-3. MLL4, UTX, and EZH2 regulate the expression of transcription factors associated with the epithelial-to-mesenchymal transition of lung cancer during metastasis to the brain at posttranscriptional steps
por: Kim, Young Zoon
Publicado: (2021)

BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
por: Schreck, Karisa C., et al.
Publicado: (2019)

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

OTME-10. Integrated analysis of human gliomas at the single cell level identifies S100A4 as a novel immunotherapy target
por: Abdelfattah, Nourhan, et al.
Publicado: (2021)

ET-8 Integrated diagnostic approach to predict prognosis for malignant gliomas
por: Isoda, Masataka, et al.
Publicado: (2021)

CS-03 BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Hayashi, Takahiro, et al.
Publicado: (2020)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

NI-10 Reclassification of diffuse gliomas based on molecular diagnosis -evaluation of methionine uptake and treatment outcome-
por: Tamura, Kaoru, et al.
Publicado: (2021)

NI-12 The ratio of T1-Weighted to T2-Weighted Signal Intensity and IDH mutation in glioma
por: Sanada, Takahiro, et al.
Publicado: (2021)

PEDT-1 Integrated diagnoses of pediatric gliomas in our institute by cIMPACT-NOW recommendations
por: Yamamura, Toshihiro, et al.
Publicado: (2021)

DDRE-08. NRF2/GLUTATHIONE METABOLISM AS A NOVEL THERAPEUTIC TARGET FOR IDH1-MUTATED GLIOMA
por: Liu, Yang, et al.
Publicado: (2021)

DDRE-27. IDH MUTATED GLIOMAS PROMOTE EPILEPTOGENESIS VIA D-2-HYDROXYGLUTARATE DEPENDENT MTOR HYPERACTIVATION
por: Mortazavi, Armin, et al.
Publicado: (2021)

OTME-4. IDH mutated gliomas promote epileptogenesis via D-2-hydroxyglutarate dependent mTOR hyperactivation
por: Mortazavi, Armin, et al.
Publicado: (2021)

BIMG-14. IDENTIFICATION OF IDH MUTATION STATUS USING PROTON MR SPECTROSCOPY AND MASS SPECTROMETRY: A STUDY OF 178 GLIOMAS
por: Sacli-Bilmez, Banu, et al.
Publicado: (2021)

BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS
por: Yamasaki, Tomohiro, et al.
Publicado: (2021)

SYST-10 CSNO2012001 STUDY: A PHASE III TRIAL ON ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA IN NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
por: Chen, Zhongping, et al.
Publicado: (2022)

SPDR-1 HSP90 inhibition overcomes resistant to molecular targeted therapy in BRAF(V600E) mutant glioblastoma
por: Sasame, Jo, et al.
Publicado: (2021)

BIMG-11. PHARMACODYNAMIC EVALUATION OF IDH AND EGFR INHIBITION IN HUMAN GLIOMAS USING MOLECULAR MRI
por: Ellingson, Benjamin, et al.
Publicado: (2021)

SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND THALAMIC GLIOMA
por: Odia, Yazmin, et al.
Publicado: (2022)

Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas
por: Schreck, Karisa C., et al.
Publicado: (2019)

STMO-03 Surgical resection for precentral gyrus glioma
por: Kijima, Noriyuki, et al.
Publicado: (2020)

DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
por: Ruiz-Rodado, Victor, et al.
Publicado: (2021)

FSMP-05. KETOGENIC DIETS FOR HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2021)

THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES
por: Lauko, Adam, et al.
Publicado: (2019)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

MPC-7 Clinical features of Diffuse hemispheric glioma, H3 G34-mutant in children and young adults
por: Takeshima, Yuki, et al.
Publicado: (2021)

SS-2 Current status and future perspective of radiomics in glioma imaging
por: Kinoshita, Manabu, et al.
Publicado: (2020)

BIMG-09. GLUTAMINE AND GLYCINE BY MR SPECTROSCOPY IDENTIFY AGGRESSIVE GLIOMAS
por: Choi, Changho, et al.
Publicado: (2021)

STMO-7 Usefulness of NU-KNIT in retractorless surgery for malignant glioma
por: Yamanaka, Yuji, et al.
Publicado: (2021)

MPC-5 Characteristics of H3 G34-mutant gliomas
por: Kibe, Yuji, et al.
Publicado: (2021)

BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
por: Munjapara, Vasu, et al.
Publicado: (2022)

MS-2 Minimally invasive glioma surgery with navigation system and tubular retractor
por: Kurozumi, Kazuhiko
Publicado: (2020)

COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a614fd6dr23tddkd52u9gmbc3t